Your browser doesn't support javascript.
loading
Multiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal study.
Torres-Martos, Álvaro; Anguita-Ruiz, Augusto; Bustos-Aibar, Mireia; Ramírez-Mena, Alberto; Arteaga, María; Bueno, Gloria; Leis, Rosaura; Aguilera, Concepción M; Alcalá, Rafael; Alcalá-Fdez, Jesús.
Afiliação
  • Torres-Martos Á; Department of Biochemistry and Molecular Biology II, School of Pharmacy, "José Mataix Verdú" Institute of Nutrition and Food Technology (INYTA) and Center of Biomedical Research, University of Granada, Granada, 18071, Spain; Instituto de investigación Biosanitaria ibs.GRANADA, Granada, 18012, Spain;
  • Anguita-Ruiz A; CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain; Barcelona Institute for Global Health, ISGlobal, Barcelona, 08003, Spain. Electronic address: augusto.anguita@isglobal.org.
  • Bustos-Aibar M; Department of Biochemistry and Molecular Biology II, School of Pharmacy, "José Mataix Verdú" Institute of Nutrition and Food Technology (INYTA) and Center of Biomedical Research, University of Granada, Granada, 18071, Spain; CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de
  • Ramírez-Mena A; Bioinformatics Unit, Centre for Genomics and Oncological Research, GENYO Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016, Spain. Electronic address: alberto.ramirez@genyo.es.
  • Arteaga M; Department of Computer Science and Artificial Intelligence, Andalusian Research Institute in Data Science and Computational Intelligence (DaSCI), University of Granada, Granada, 18071, Spain. Electronic address: mariaartj@correo.ugr.es.
  • Bueno G; CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain; Growth, Exercise, Nutrition and Development (GENUD) Research Group, Institute for Health Research Aragón (IIS Aragón), Zaragoza, 50009, Spain; Pediatric Endocrinology Unit, Facultad de
  • Leis R; CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain; Unit of Pediatric Gastroenterology, Hepatology and Nutrition, Pediatric Service, Hospital Clínico Universitario de Santiago. Unit of Investigation in Nutrition, Growth and Human Develo
  • Aguilera CM; Department of Biochemistry and Molecular Biology II, School of Pharmacy, "José Mataix Verdú" Institute of Nutrition and Food Technology (INYTA) and Center of Biomedical Research, University of Granada, Granada, 18071, Spain; Instituto de investigación Biosanitaria ibs.GRANADA, Granada, 18012, Spain;
  • Alcalá R; Department of Computer Science and Artificial Intelligence, Andalusian Research Institute in Data Science and Computational Intelligence (DaSCI), University of Granada, Granada, 18071, Spain. Electronic address: alcala@decsai.ugr.es.
  • Alcalá-Fdez J; Department of Computer Science and Artificial Intelligence, Andalusian Research Institute in Data Science and Computational Intelligence (DaSCI), University of Granada, Granada, 18071, Spain. Electronic address: jalcala@decsai.ugr.es.
Artif Intell Med ; 156: 102962, 2024 Aug 20.
Article em En | MEDLINE | ID: mdl-39180924
ABSTRACT
Pediatric obesity can drastically heighten the risk of cardiometabolic alterations later in life, with insulin resistance standing as the cornerstone linking adiposity to the increased cardiovascular risk. Puberty has been pointed out as a critical stage after which obesity-associated insulin resistance is more difficult to revert. Timely prediction of insulin resistance in pediatric obesity is therefore vital for mitigating the risk of its associated comorbidities. The construction of effective and robust predictive systems for a complex health outcome like insulin resistance during the early stages of life demands the adoption of longitudinal designs for more causal inferences, and the integration of factors of varying nature involved in its onset. In this work, we propose an eXplainable Artificial Intelligence-based decision support pipeline for early diagnosis of insulin resistance in a longitudinal cohort of 90 children. For that, we leverage multi-omics (genomics and epigenomics) and clinical data from the pre-pubertal stage. Different data layers combinations, pre-processing techniques (missing values, feature selection, class imbalance, etc.), algorithms, training procedures were considered following good practices for Machine Learning. SHapley Additive exPlanations were provided for specialists to understand both the decision-making mechanisms of the system and the impact of the features on each automatic decision, an essential issue in high-risk areas such as this one where system decisions may affect people's lives. The system showed a relevant predictive ability (AUC and G-mean of 0.92). A deep exploration, both at the global and the local level, revealed promising biomarkers of insulin resistance in our population, highlighting classical markers, such as Body Mass Index z-score or leptin/adiponectin ratio, and novel ones such as methylation patterns of relevant genes, such as HDAC4, PTPRN2, MATN2, RASGRF1 and EBF1. Our findings highlight the importance of integrating multi-omics data and following eXplainable Artificial Intelligence trends when building decision support systems.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article